CA2665726C — Pharmaceutical compositions
Assigned to Alpharma Pharmaceuticals LLC · Expires 2016-04-19 · 10y expired
What this patent protects
Provided herein is a method of treating a condition in a host that is responsive to an agonist, the method comprising administering to the host a multi-layer pharmaceutical composition comprising the agonist eg. an opioid and an antagonist eg. naltrexone thereof, wherein the agon…
USPTO Abstract
Provided herein is a method of treating a condition in a host that is responsive to an agonist, the method comprising administering to the host a multi-layer pharmaceutical composition comprising the agonist eg. an opioid and an antagonist eg. naltrexone thereof, wherein the agonist and antagonist are not in direct contact with one another in the intact form of the composition.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.